Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name	PI Organization	Title	Grant Number	Program Official Sort descending
Majumder, Shounak	Mayo Clinic Rochester United States	Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer	5U01CA210138-09	Matthew Young, Ph.D.
Godwin, Andrew K.	University Of Kansas Medical Center United States	Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem	5R01CA260132-05	Matthew Young, Ph.D.
Zhu, Yazhen	University Of California Los Angeles United States	Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma	5R01CA255727-05	Matthew Young, Ph.D.
Wolpin, Brian Matthew	Dana-Farber Cancer Inst United States	Altered metabolism and machine learning for pancreatic cancer early detection	5U01CA210171-09	Matthew Young, Ph.D.
Justilien, Verline	Mayo Clinic Jacksonville United States	ECT2 Isoform Switch in Pancreatic Cancer.	5R21CA296671-02	Matthew Young, Ph.D.
Goel, Ajay	Beckman Research Institute/City Of Hope United States	Exosomal biomarkers for the early detection of hepatocellular carcinoma	5R01CA271443-03	Matthew Young, Ph.D.
Allen, Peter J	Duke University United States	Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas	5R01CA182076-08	Matthew Young, Ph.D.
Elenitoba-Johnson, Kojo S. J.	Sloan-Kettering Inst Can Research United States	Genomic biomarkers of splenic lymphoma	5R01CA255655-06	Nicholas Hodges, Ph.D.
Kuhn, Peter	University Of Southern California United States	Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma	4U01CA285013-03	Nicholas Hodges, Ph.D.
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-11	Nicholas Hodges, Ph.D.
Shain, Alan Hunter	University Of California, San Francisco United States	Pre-cancer atlas of skin cancer	4U01CA294536-02	Nicholas Hodges, Ph.D.
Frazier, Anne Lindsay	Dana-Farber Cancer Inst United States	Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors	5UH3CA240688-05	Nicholas Hodges, Ph.D.
Zhou, Xianghong Jasmine	University Of California Los Angeles United States	Multi-cancer early detection using cell-free DNA methylome analysis	5U01CA285010-03	Nicholas Hodges, Ph.D.
Slager, Susan L	Mayo Clinic Rochester United States	The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)	4R01CA258465-04	Nicholas Hodges, Ph.D.
Papadopoulos, Nickolas	Johns Hopkins University United States	Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids	5U01CA230691-08	Nicholas Hodges, Ph.D.